Skip to main content
. 2018 Nov 29;7(11):e11139. doi: 10.2196/11139

Figure 5.

Figure 5

Comparison between 3 subchronic doses of methylsulfonylmethane (MSM; 1 g, 3 g, and 6 g): percentage change in visual analog scale nasal obstruction from V1 (screening) to V3 (day 14). Significance was tested using linear mixed model analysis. *P ≤.05; **P ≤.01.